Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Mimedx (MDXG) Shares Repurchased (2016 - 2018)

Mimedx's Shares Repurchased history spans 5 years, with the latest figure at $7.6 million for Q1 2018.

On a quarterly basis, Shares Repurchased rose 159.78% to $7.6 million in Q1 2018 year-over-year; TTM through Dec 2018 was $7.6 million, a 88.91% decrease, with the full-year FY2023 number at $9.5 million, changed N/A from a year prior.
Shares Repurchased hit $7.6 million in Q1 2018 for Mimedx, down from $112.3 million in the prior quarter.
Over the last five years, Shares Repurchased for MDXG hit a ceiling of $112.3 million in Q4 2017 and a floor of -$29.3 million in Q3 2017.
Historically, Shares Repurchased has averaged $1.4 million across 5 years, with a median of -$4.0 million in 2015.
Biggest five-year swings in Shares Repurchased: tumbled 6303.67% in 2015 and later skyrocketed 159.78% in 2018.
Tracing MDXG's Shares Repurchased over 5 years: stood at -$300000.0 in 2014, then plummeted by 6303.67% to -$19.2 million in 2015, then soared by 64.35% to -$6.8 million in 2016, then soared by 1739.82% to $112.3 million in 2017, then plummeted by 93.26% to $7.6 million in 2018.
Business Quant data shows Shares Repurchased for MDXG at $7.6 million in Q1 2018, $112.3 million in Q4 2017, and -$29.3 million in Q3 2017.